Physician profile
Steven Risman
NPI 1427108554
$1,091.24
in general payments reported to CMS, 2019-2025
19 companies · $13.77 in 2025
The $13.77 reported for 2025 was less than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $309 · 2021: $83.82 · 2022: $190 · 2023: $222 · 2025: $13.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $236.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $317.56 | 2019-2023 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals Lp | $241.44 | 2020-2023 | Breztri, Farxiga |
| Almatica Pharma LLC | $71.76 | 2022 | |
| Genentech USA, INC. | $51.92 | 2019-2022 | |
| Allergan, INC. | $44.90 | 2020 | |
| Merck Sharp & Dohme LLC | $42.21 | 2019-2022 | |
| Bausch Health US, LLC | $40.44 | 2022 | |
| Lilly USA, LLC | $39.20 | 2019-2020 | |
| Glaxosmithkline, LLC. | $38.07 | 2019-2020 | |
| Pfizer INC. | $28.12 | 2019-2025 | |
| Nabriva Therapeutics, Plc | $27.10 | 2020-2021 | |
| Avanir Pharmaceuticals, INC. | $26.10 | 2019 | |
| Exact Sciences Corporation | $24.89 | 2023 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $23.56 | 2019 | |
| Novartis Pharmaceuticals Corporation | $21.32 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $14.73 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.18 | 2022 | |
| Alk-Abello, INC | $12.74 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Risman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.